Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $33.0000 (4.43%) ($31.6200 - $35.5500) on Fri. May. 4, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 44 | Latest Price | $33.0000(4.43%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EDIT declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.805% in a week (0% probabilities). VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
Resistance Level | $33.49 | 5 Day Moving Average | $32.23(2.39%) | 10 Day Moving Average | $32.47(1.63%) | 20 Day Moving Average | $33.49(-1.46%) | To recent high | -25.1% | To recent low | 5.1% | Market Cap | $2.049b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |